The Safety of Pharmacopuncture on Musculoskeletal Patients

Jaseng Medical Foundation

Status: Completed

Conditions: Spine; Arthrosis; Musculoskeletal Diseases or Conditions

Treatments: Other: Pharmacopuncture

Study type: Observational

Funder types: Other

Identifiers

NCT05318859

JS-CT-2021-17

Details and patient eligibility

About

The purpose of this study is to evaluate the safety of pharmacopuncture by observing any adverse events that may occur after pharmacopuncture treatment in with spinal joint disease hospitalized patients at 7 Korean medicine hospitals and analyzing blood test results.

Full description

This study was an registry observational study, and was conducted in 7 Korean medicine hospitals (160 patients at Jaseng Korean medicine Hospital, 140 patients at Daejeon Jaseng Hospital of Korean Medicine, 140 patients at Bucheon Jaseng Hospital of Korean Medicine, 140 patients at Haeundae Jaseng Korean medicine Hospital, 140 patients at Kyunghee University of Korean medicine Hospital, 140 patients at Kyung Hee University of Korean Medicine Hospital at Gangdong, and 140 patients at Dongguk University Bundang Oriental Hospital).

Enrollment: 1,000 patients

Sex: All

Ages: 19 to 69 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Inpatients with diagnosed spinal joint disease
• Patients who received pharmacopuncture treatment during hospitalization
• Patients who are 19 years of age or older and less than 70 years old
• Patients who agreed to participate in the clinical study and voluntarily given written informed consent

Exclusion criteria

• Patients with difficulty or refusal to give sign written informed consent
• Patients for whom the researchers judge participation in the clinical study to be difficult